Abstract

Four direct oral anticoagulants (DOACs) are all recommended as options for people with atrial fibrillation (AF) and a CHA2DS2‑VASc score of 2 or above for the prevention of stroke, new guidance from the National Institute for Health and Care Excellence (NICE) has said. The final guideline, which was published on 27 April 2021, has been […]

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.